Net revenue for the third quarter increased 8.0% year over year to $99.6 million, including a $0.8 million non-cash reduction ...

CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit ...

Gross margin for 2025 was 31.8% (non-GAAP), up from 28.8% in 2024, at the upper end of the company’s targeted 27%-32% range ...

Simplify Excel file sharing and exporting. Learn how to collaborate in the cloud, email files, and manage formats with ease.

NCS Multistage Holdings, Inc. ( NCSM) Q3 2025 Earnings Call October 30, 2025 8:30 AM EDT Good day, and thank you for standing by. Welcome to the NCS Multistage Q3 2025 Earnings Conference Call.

Flushing Financial Corporation ( FFIC) Q3 2025 Earnings Call October 30, 2025 9:30 AM EDT ...

PYRUKYND® (mitapivat) net revenuesPDUFA goal date for PYRUKYND U.S. sNDA in thalassemia set for December 7, 2025CHMP adopted positive opinion for PYRUKYND in thalassemia; EC decision expected by early ...

Q3 2025 Earnings Call Transcript October 29, 2025 Verisk Analytics, Inc. beats earnings expectations. Reported EPS is $1.72, ...

Swiss has taken the drastic step of grounding its fleet of nine Airbus A220-100s to serve as engine donors to keep its ...

Q3 2025 Earnings Call Transcript October 29, 2025 Otis Worldwide Corporation beats earnings expectations. Reported EPS is ...